Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin

Epilepsia

Volumn 51, Issue 9, 2010, Pages 1714-1720

  Hassel, Bjørnar ^a,b   Taubøll, Erik ^a   Shaw, Renee ^c   Gjerstad, Leif ^a   Dingledine, Ray ^c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiepileptic drugs; Brain region; Epilepsy; mRNA; Transcription

Indexed keywords

ETIRACETAM; MESSENGER RNA; OLIGONUCLEOTIDE; PHENYTOIN; ANTICONVULSIVE AGENT; PIRACETAM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DNA MICROARRAY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; GENE TARGETING; GENETIC VARIABILITY; HIPPOCAMPUS; LONG TERM CARE; MEDULLA OBLONGATA; NONHUMAN; PHARMACOGENETICS; PONS; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL MODEL; BRAIN; COMPARATIVE STUDY; DRUG EFFECTS; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROCEDURES; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; ANTICONVULSANTS; BRAIN; FEMALE; FRONTAL LOBE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MEDULLA OBLONGATA; MODELS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENYTOIN; PIRACETAM; PONS; RATS; RATS, WISTAR; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 77956309740     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02545.x     Document Type: Article

References (43)

1. Bechade C, Sur C, Triller A 1994) The inhibitory neuronal glycine receptor. Bioessays 16 : 735 744.
2. Bengzon J, Kalen P, Lindvall O 1990) Evidence for long-term reduction of noradrenaline release after kindling in the rat hippocampus. Brain Res 535 : 353 357.
3. Benjamini Y, Hochberg Y 1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57 : 289 300.
4. Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, Shaw R, Smith Y, Geiger JD, Dingledine RJ 2006) Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 60 : 223 235.
5. Brunbech L, Sabers A 2002) Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents. Drugs 62 : 593 604.
6. Budzinski KL, Allen RW, Fujimoto BS, Kensel-Hammes P, Belnap DM, Bajjalieh SM, Chiu DT 2009) Large structural change in isolated synaptic vesicles upon loading with neurotransmitter. Biophys J 97 : 2577 2584.
7. Catterall WA, Goldin AL, Waxman SG 2005) International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 57 : 397 409.
8. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, Watson SJ, Meng F 2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33 : e175.
9. Fuks B, Gillard M, Michel P, Lynch B, Vertongen P, Leprince P, Klitgaard H, Chatelain P 2003) Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines. Eur J Pharmacol 478 : 11 19.
10. Gu J, Lynch BA, Anderson D, Klitgaard H, Lu S, Elashoff M, Ebert U, Potschka H, Löscher W 2004) The antiepileptic drug levetiracetam selectively modifies kindling-induced alterations in gene expression in the temporal lobe of rats. Eur J Neurosci 19 : 334 345.
11. Hassel B, Iversen EG, Gjerstad L, Taubøll E 2001a) Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate. J Neurochem 77 : 1285 1292.
12. Hassel B, Taubøll E, Gjerstad L 2001b) Chronic lamotrigine treatment increases rat hippocampal GABA shunt activity and elevates cerebral taurine levels. Epilepsy Res 43 : 153 163.
13. Hensler JG 2006) Serotonin. In Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry, 7th ed. Elsevier, Amsterdam, pp. 227 248.
14. Hong SJ, Li H, Becker KG, Dawson VL, Dawson TM 2004) Identification and analysis of plasticity-induced late-response genes. Proc Natl Acad Sci USA 101 : 2145 2150.
15. Janumpalli S, Butler LS, MacMillan LB, Limbird LE, McNamara JO 1998) A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine. J Neurosci 18 : 2004 2008.
16. Joerger M, Huitema AD, Boogerd W, van der Sande JJ, Schellens JH, Beijnen JH 2006) Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients. Basic Clin Pharmacol Toxicol 99 : 133 140.
17. Johannessen SI, Battino D, Berry DJ, Bialer M, Kramer G, Tomson T, Patsalos PN 2003) Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25 : 347 363.
18. Kälviäinen R, Khyuppenen J, Koskenkorva P, Eriksson K, Vanninen R, Mervaala E 2008) Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia 49 : 549 556.
19. Krauss GL, Mathews GC 2003) Similarities in mechanisms and treatments for epileptic and nonepileptic myoclonus. Epilepsy Curr 3 : 19 21.
20. L'Estrange Orme M, Borga O, Cook CE, Sjoqvist F 1976) Measurement of diphenylhydantoin in 0.1-ml plasma samples: gas chromatography and radioimmunoassay compared. Clin Chem 22 : 246 249.
21. Löscher W, Hörstermann D 1994) Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma. Naunyn Schmiedebergs Arch Pharmacol 349 : 270 278.
22. Löscher W, Hönack D, Bloms-Funke P 1996) The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata. Brain Res 735 : 208 216.
23. Lukyanetz EA, Shkryl VM, Kostyuk PG 2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43 : 9 18.
24. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B 2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101 : 9861 9866.
25. Niespodziany I, Klitgaard H, Margineanu DG 2004) Is the persistent sodium current a specific target of anti-absence drugs? Neuroreport 15 : 1049 1052.
26. Noebels JL, Rutecki PA 1990) Altered hippocampal network excitability in the hypernoradrenergic mutant mouse tottering. Brain Res 524 : 225 230.
27. Potschka H, Baltes S, Löscher W 2004) Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats. Epilepsy Res 58 : 85 91.
28. Prasad A, Kuzniecky RI, Knowlton RC, Welty TE, Martin RC, Mendez M, Faught RE 2003) Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Arch Neurol 60 : 1100 1105.
29. Racine R, Coscina DV 1979) Effects of midbrain raphe lesions or systemic p-chlorophenylalanine on the development of kindled seizures in rats. Brain Res Bull 4 : 1 7.
30. Raisinghani M, Faingold CL 2005) Pontine reticular formation neurons are implicated in the neuronal network for generalized clonic seizures which is intensified by audiogenic kindling. Brain Res 1064 : 90 97.
31. Ratnaraj N, Doheny HC, Patsalos PN 1996) A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb LO59) in serum or plasma by high performance liquid chromatography. Ther Drug Monit 18 : 154 157.
32. Rigo JM, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B, Leprince P, Moonen G, Selak I, Matagne A, Klitgaard H 2002) The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136 : 659 672.
33. Seegers U, Potschka H, Löscher W 2002) Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions. Eur J Pharmacol 451 : 149 155.
34. Shannon HE, Love PL 2007) Effects of antiepileptic drugs on learning as assessed by a repeated acquisition of response sequences task in rats. Epilepsy Behav 10 : 16 25.
35. Tudur Smith C, Marson AG, Clough HE, Williamson PR 2002) Carbamazepine versus phenytoin monotherapy for epilepsy. Cochrane Database Syst Rev CD001911.
36. Tunnicliff G 1996) Basis of the antiseizure action of phenytoin. Gen Pharmacol 27 : 1091 1097.
37. Tusher VG, Tibshirani R, Chu G 2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98 : 5116 5121.
38. van Vliet EA, van Schaik R, Edelbroek PM, Voskuyl RA, Redeker S, Aronica E, Wadman WJ, Gorter JA 2007) Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats. J Pharmacol Exp Ther 322 : 141 147.
39. van Vliet EA, van Schaik R, Edelbroek PM, Lopes da Silva FH, Wadman WJ, Gorter JA 2008) Development of tolerance to levetiracetam in rats with chronic epilepsy. Epilepsia 49 : 1151 1159.
40. Walling SG, Harley CW 2004) Locus ceruleus activation initiates delayed synaptic potentiation of perforant path input to the dentate gyrus in awake rats: a novel betaadrenergic- and protein synthesis-dependent mammalian plasticity mechanism. J Neurosci 24 : 598 604.
41. Westenbroek R, Hell JW, Warner C, Dubel SJ, Snutch TP, Catterall WA 1992) Biochemical properties and subcellular distribution of an N-type calcium channel 1 subunit. Neuron 9 (subunit 1099 1115.
42. Worley PF, Baraban JM 1987) Site of anticonvulsant action on sodium channels: autoradiographic and electrophysiological studies in rat brain. Proc Natl Acad Sci USA 84 : 3051 3055.
43. 2+ currents. Seizure 10 : 279 286.